Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study - Wikidata - awgldk - TriplyDB

Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study

Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study

http://www.wikidata.org/entity/Q37570185

about

An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review Age-Related Macular Degeneration: Advances in Management and Diagnosis Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development Does Testing More Frequently Shorten the Time to Detect Disease Progression?Self-Testing of Vision in Age-Related Macula Degeneration: A Longitudinal Pilot Study Using a Smartphone-Based Rarebit Test.Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).The reduction of serum soluble Flt-1 in patients with neovascular age-related macular degeneration Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study.The Chronic Care for Wet Age Related Macular Degeneration (CHARMED) Study: A Randomized Controlled Trial.UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12 Strategies for improving early detection and diagnosis of neovascular age-related macular degeneration.The Current State of Teleophthalmology in the United States.Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System.Assessment of visual distortions in age-related macular degeneration: emergence of new approaches.Improved Adherence to Vision Self-monitoring with the Vision and Memory Stimulating (VMS) Journal for Non-neovascular Age-related Macular Degeneration during a Randomized Controlled Trial.Reaching the Unreachable: Novel Approaches to Telemedicine Screening of Underserved Populations for Vitreoretinal Disease.Recent developments in age-related macular degeneration: a review.EFFECTIVENESS OF DIFFERENT MONITORING MODALITIES IN THE DETECTION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Home Study, Report Number 3 Validation of a Tablet as a Tangent Perimeter.Advances in technology helps in early detection of vision disorders.Gaming to improve vision: 21st century self-monitoring for patients with age-related macular degeneration.Accuracy of a Self-monitoring Test for Identification and Monitoring of Age-related Macular Degeneration: A Diagnostic Case-control Study.The accuracy of home monitoring to detect disease activity during maintenance therapy for neovascular ARMD.Home Monitoring of Retinal Sensitivity on a Tablet Device in Intermediate Age-Related Macular Degeneration

P2860

Q26777085-C9FA519A-065F-4FFF-918D-90C71399B535 Q26799617-BE4869B7-359D-4350-BCAD-6CC59B5518B3 Q26824335-1D3ABFA5-36CB-4202-A236-05B590ED6AE8 Q30847473-B033958F-14DB-4C2E-86AC-62469F47413F Q33444081-DC00B10D-9455-4480-9962-3D0D66C09649 Q33891126-93F1F9FA-9B9E-47F0-94C9-1C7DF726DC89 Q34092454-DA0A36EB-C941-450D-A6C8-8342A88E4537 Q34674568-4F1DD0F4-2501-457F-88F5-8D463C7B470F Q35118257-A8E07A05-22FC-4273-88B7-80ACFE0D8C82 Q35716443-8540EE43-4B50-4FDF-AC0A-D7B30207D015 Q35841740-04A3094D-9AF3-4BFE-9AA4-F13D3D5DA6BC Q36028992-2FF19B40-DAF7-40D6-81BD-4B9AC1B88ADC Q38367104-813C1736-3C0C-489A-B024-C33DD72E76A3 Q38667170-3055329E-0532-470E-B442-7B0D26930A01 Q38867052-C7644D19-CD07-4E91-90AC-3797C6A621CB Q38979931-82CED5DF-9CEB-48E9-A718-28E3CA1BD8F5 Q39042323-62179DB9-2E6E-4BA4-925A-A253AF139D2C Q39307436-448E9D83-0152-4495-A8CF-5471197F81A1 Q41532061-7F3B1CA1-24F1-4CED-9157-B6292B4522A9 Q42132292-E3019A3A-CD44-439F-A942-5DF905268BE8 Q42406207-5E5E0A60-DD7F-485C-B487-EB0EFAA16E26 Q42565175-65DC4DDF-6D23-4245-96B8-81405C03630C Q47355167-853AD8DA-0531-49C2-8EE3-763503B063B4 Q52606074-F14FF448-13D0-4FD2-80E8-FA6A807507E3 Q52838532-4297007D-CDC4-4338-AAD7-0AF1BDCCB483 Q58599946-D164C80C-11AD-464B-93E3-4F7C3DD89ABB

P2860

Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study

http://www.wikidata.org/entity/Q37570185

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Randomized trial of a home mon ...... toring of the Eye (HOME) study

@en

Randomized trial of a home mon ...... ion home monitoring of the Eye

@nl

type

label

Randomized trial of a home mon ...... toring of the Eye (HOME) study

@en

Randomized trial of a home mon ...... ion home monitoring of the Eye

@nl

prefLabel

Randomized trial of a home mon ...... toring of the Eye (HOME) study

@en

Randomized trial of a home mon ...... ion home monitoring of the Eye

@nl

P1433

Q37570185-9B8EE2E7-93F6-47C0-8171-C0B4E6FC34DD

P1476

Q37570185-64A2BC29-E8F2-4037-9CA2-5A9A0194D191

P2093

Q37570185-0BB3B331-D081-4AB2-B3EF-9AAB346F019B

Q37570185-15BCBD2D-F020-43CA-8A89-84AC4324155A

Q37570185-3045A619-7448-4635-ACD2-91BA79023E69

Q37570185-4D826636-A51B-49CE-9DA9-ED5841F49477

Q37570185-58A5E4A9-B290-4F38-9F2E-3B9DAE130C28

Q37570185-600A67C6-65CB-4276-B697-A7C32D35CF89

Q37570185-A8B67078-C9EA-4822-B066-12390FCCF605

Q37570185-D59B8128-A078-443C-B851-0B153BA453BA

Q37570185-E65D8B52-27E4-446D-B72A-D90316ACCA33

P2860

Q37570185-00116C54-BF46-4401-9605-8BC9104814CA

Q37570185-0456A62F-80DC-4B1F-8239-C52B045970E8

Q37570185-06594CA6-A2A2-409F-8265-F3601D7B4E68

Q37570185-0F11075A-4A1E-48DA-B5D5-DC286359EC58

Q37570185-10216BC2-1E82-4566-A4B4-88C15A69CE52

Q37570185-302CCA97-7942-4F8C-8BAA-D97A811AC3DD

Q37570185-312B141F-30E4-47CD-868B-2C5B8A554E31

Q37570185-41DD2833-1A04-4164-8904-93AA229EF7B2

Q37570185-43DD9530-7890-4942-A5AA-FE8534E0F788

Q37570185-53B4DBD7-9278-4F5F-B159-552F0A74496B

P304

Q37570185-94987872-FCB2-42B5-BF60-C440B4E50429

P31

Q37570185-41E99820-6231-4793-A3CF-5F2E7FEA82C0

P356

Q37570185-8E5792BB-E11D-4356-92EF-F7D8A531EC1D

P433

Q37570185-93080D8C-DF95-4696-9F31-CF1EC189C056

P478

Q37570185-A65889C4-2B6D-42C8-91C4-A3A187FA3BC6

P50

Q37570185-D0BF080E-929D-486E-BAC1-C7DF5F3D6D3A

P577

Q37570185-D8382619-8E07-4227-8204-E5A7A44E4679

P698

Q37570185-10AADF76-CA64-4A47-B2BF-2B35439D1887

P921

Q37570185-11DBEFB6-F032-4C1F-A894-00C66CB0F34B

P932

Q37570185-B38F9D1E-DA6F-4993-8174-76313C1C2D07

P356

J.OPHTHA.2013.10.027

P1433

P1476

Randomized trial of a home mon ...... toring of the Eye (HOME) study

@en

P2093

AREDS2-HOME Study Research Group

http://www.w3.org/2001/XMLSchema#string

Amitha Domalpally

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Heier

http://www.w3.org/2001/XMLSchema#string

Judy E Kim

http://www.w3.org/2001/XMLSchema#string

Michael J Elman

http://www.w3.org/2001/XMLSchema#string

Richard Garfinkel

http://www.w3.org/2001/XMLSchema#string

Ronald P Danis

http://www.w3.org/2001/XMLSchema#string

Susan B Bressler

http://www.w3.org/2001/XMLSchema#string

Traci E Clemons

http://www.w3.org/2001/XMLSchema#string

P2860

Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial

Prevalence of age-related macular degeneration in the United States

Ranibizumab for neovascular age-related macular degeneration

2002 global update of available data on visual impairment: a compilation of population-based prevalence studies.

Comparison of the original Amsler grid with the preferential hyperacuity perimeter for detecting choroidal neovascularization in age-related macular degeneration.

Long-term monitoring of age-related macular degeneration with preferential hyperacuity perimetry.

Editorial: Visual acuity and hyperacuity.

Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.

Intravitreal bevacizumab and ranibizumab for age-related macular degeneration a multicenter, retrospective study.

Longitudinal analysis of the relationship between regular eye examinations and changes in visual and functional status.

P304

535-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OPHTHA.2013.10.027

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24211172

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

3918479

http://www.w3.org/2001/XMLSchema#string